Ernexa Therapeutics Inc. (ERNA)

NASDAQ: ERNA · Real-Time Price · USD

0.2005

-0.0100 (-4.75%)

At close: Apr 2, 2026, 4:00 PM EDT

0.2000

-0.0005 (-0.25%)

After-hours: Apr 2, 2026, 7:16 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Research and Development of Cellular Therapies	582.00K	68.00K	-	-
Research and Development of Cellular Therapies Growth	755.88%	-	-	-
Total	582.00K	68.00K	-	-
Total Growth	755.88%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	582.00K	68.00K	-	-
United States Growth	755.88%	-	-	-
Total	582.00K	68.00K	-	-
Total Growth	755.88%	-	-	-

Source: S&P Global Market Intelligence.